Evidity Health Capital โ Full Portfolio
16 tracked investments ยท listed companies and verified rows first
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Buzz Benson(Director)Arjun Arora(Director)Jason Tester(Chief Financial Officer and Secretary)Richard L. Lindstrom, M.D.(Director)James Garvey(Director)
HealthtechBoston, US
ERIC ELENKO(Executive Officer, Director)ROBERT PEREZ(Director)BHARATT CHOWRIRA(Director)W. EDWARD MARTUCCI(Executive Officer, Director)JAMES GATES(Director)JOICHI ITO(Director)
HealthtechSan Diego, US
Nicholas Barthelemy(Executive Officer, Director, Promoter)David Kabakoff(Director)Eric Bednarski(Director)
BoardAlejandro Sanchez(Director)
HealthtechSanta Clara, US
George Lee(Director)Lisa Garrett(Executive Officer)Michael Bornitz(Director)Rick Anderson(Director)John Russell(Executive Officer, Director)Augustine Lien(Director)
Tissue characterization technology company whose MarginProbe System detects cancer in real time during breast surgery.
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Michael Carusi(Director)Scott Ward(Director)Arda Minocherhomjee(Director)Philip Macdonald(Executive Officer)Jordan Davis(Director)Lee Wrubel, M.D.(Director)
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)Jason Rostovsky(Director)James Leech(Executive Officer)Radu Cautis(Director)Matthew E. Likens(Executive Officer, Director)
Magnolia Medical develops the Steripathยฎ platform, an FDA-cleared medical device designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing in hospital settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Paul Meister(Director)Richard G Patton(Director)Gregory J Bullington(Executive Officer, Director)
HealthtechPembroke Pines, US
Horace Richard Davis(Executive Officer)
PreludeDx develops DCISionRT, a biomarker-based diagnostic test for ductal carcinoma in situ (DCIS) breast cancer that helps physicians predict a patient's recurrence risk and whether they would benefit from radiation therapy after breast-conserving surgery.
BiotechHealthtechMedical Devices
Sonde provides an API/SDK platform that analyzes vocal biomarkers to detect health signals from voice, offering insights into users' mental, cognitive, and respiratory fitness.
AI & Machine LearningDigital HealthHealthtech
BiotechCambridge, US
Nathaniel Weiss(Executive Officer, Director)David Artz(Director)Andrew Smith(Director)
Rows marked โSEC filingโ are inferred from directors named on the company's SEC Form D โ public regulatory data, not a portfolio list published by the firm.